Skip to Content
Søk Menu

Den største studien om metastatisk  urotelialt  karsinom per dags dato

Få tilgang

Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.

Relatert innhold

Ahmed Rehan

Real-World Data on Maintenance Avelumab Treatment

/ Ahmed Rehan
ASCOGU24Blærekreft Play the Video 2:14
Petros Grivas

Long-Term Patient-Reported Outcomes Data from the JAVELIN Bladder 100 Trial in Patients with Advanced Urothelial Carcinoma

/ Petros Grivas
ASCOGU24Blærekreft Play the Video 02:14
Andrea Apolo

Results from Study of Pembrolizumab in Muscle-Invasive and Locally Advanced Urothelial Carcinoma

/ Andrea Apolo
ASCOGU24Blærekreft Play the Video 02:02
Philippe Barthelemy

Real-World Data on Avelumab as 1L Maintenance Treatment

/ Philippe Barthelemy
ASCOGU24Blærekreft Play the Video 02:48
Jeanny B. Aragon-Ching

JAVELIN Bladder 100 Trial: Strong Avelumab Maintenance Efficacy in High BMI Patients

/ Jeanny B. Aragon-Ching
ASCOGU24BlærekreftBMI Play the Video 02:40
Srikala Sridhar

Promising Results for Enfortumab Vedotin in Neoadjuvant Treatment of Cisplatin-Ineligible Muscle-Invasive Bladder Cancer

/ Srikala Sridhar
Blærekreft Play the Video 05:10
Daniel Heinrich

ESMO 2023: Dobling av overlevelsesraten ved innovativ behandling for metastatisk blærekreft

/ Daniel Heinrich
BlærekreftESMO23 Play the Video 2:52
Arlene Siefker-Radtke

Urothelial Cancer: One Step Forward to Understand How to Combine and Sequence Treatments Against Novel Targets

/ Arlene O. Siefker-Radtke
BlærekreftESMO23 Play the Video 5:14
Thomas Powles

Keynote A39: Enfortumab Vedotin + Pembrolizumab agroundbreaking First Line Treatment in Untreated la/mUC

/ Thomas Powles
BlærekreftESMO23 Play the Video 02:51
Back to top